StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly u.S. GTN rebate, discount & return liability rollforward — Ending balance ($M) ($M)

Form 10-K Item 7 Gross-to-Net (GTN) Rollforward Table (FY2016 → FY2025)

Latest, FY2025
15,148
Period ended Dec 31, 2025
Change on a year earlier
+46.9%
10,313 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. GTN rebate, discount & return liability rollforward — Ending balance ($M) ($M)Year on yearSource
FY2025Dec 31, 202515,148+46.9%Form 10-K FY2025 (filed 2026-02-12) ↗
FY2024Dec 31, 202410,313-3.3%Form 10-K FY2024 (filed 2025-02-19) ↗
FY2023Dec 31, 202310,668+29.9%Form 10-K FY2023 (filed 2024-02-21) ↗
FY2022Dec 31, 20228,214+33.3%Form 10-K FY2022 (filed 2023-02-22) ↗
FY2021Dec 31, 20216,162+14.1%Form 10-K FY2021 (filed 2022-02-23) ↗
FY2020Dec 31, 20205,400+16.5%Form 10-K FY2020 (filed 2021-02-17) ↗
FY2019Dec 31, 20194,636-0.9%Form 10-K FY2019 (filed 2020-02-19) ↗
FY2018Dec 31, 20184,678+12.1%Form 10-K FY2018 (filed 2019-02-19) ↗
FY2017Dec 31, 20174,172+15.8%Form 10-K FY2017 (filed 2018-02-20) ↗
FY2016Dec 31, 20163,602–Form 10-K FY2017 (filed 2018-02-20) ↗

Breakdown

What makes up u.s. gtn rebate, discount & return liability rollforward — ending balance ($m)

Cite this data

StockData. (2026). Eli Lilly U.S. GTN rebate, discount & return liability rollforward — Ending balance ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/gtn_us_end

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.